Combination therapy for manic phases: a critical review of a common practice (Q34308027)

23095277

1 August 2017

title

Combination therapy for manic phases: a critical review of a common practice (English)

1 reference

1 August 2017

1 reference

ChEBI release 2020-05-28

ChEBI ID

71253

author

Pierre Alexis Geoffroy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493634&resulttype=core&format=json

14 May 2020

Bruno Etain

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493634&resulttype=core&format=json

14 May 2020

Frank Bellivier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493634&resulttype=core&format=json

14 May 2020

author name string

Chantal Henry

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493634&resulttype=core&format=json

14 May 2020

publication date

25 October 2012

1 reference

23095277

CNS Neuroscience & Therapeutics

1 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493634&resulttype=core&format=json

14 May 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493634&resulttype=core&format=json

14 May 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493634&resulttype=core&format=json

14 May 2020

page(s)

957-964

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493634&resulttype=core&format=json

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania

14 May 2020

cites work

1 reference

Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology

21 January 2018

1 reference

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

21 January 2018

1 reference

Clinical practice recommendations for bipolar disorder

21 January 2018

1 reference

New treatment guidelines for acute bipolar mania: a critical review

21 January 2018

1 reference

Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004.

21 January 2018

1 reference

2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery.

21 January 2018

1 reference

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group

21 January 2018

1 reference

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

21 January 2018

1 reference

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

21 January 2018

1 reference

A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania

21 January 2018

1 reference

Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial

21 January 2018

1 reference

Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms

21 January 2018

1 reference

A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania

21 January 2018

1 reference

Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania

21 January 2018

1 reference

Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study

21 January 2018

1 reference

Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes

21 January 2018

1 reference

Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.

21 January 2018

1 reference

Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania

21 January 2018

1 reference

Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: A randomized, placebo-controlled study

21 January 2018

1 reference

Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension

21 January 2018

1 reference

Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania

21 January 2018

1 reference

Use of antipsychotic drugs and lithium in mania

21 January 2018

1 reference

Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis

21 January 2018

1 reference

Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials

21 January 2018

1 reference

Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.

21 January 2018

1 reference

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial

21 January 2018

1 reference

Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).

21 January 2018

1 reference

Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).

21 January 2018

1 reference

Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.

21 January 2018

1 reference

Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone

21 January 2018

1 reference

Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial

21 January 2018

1 reference

Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study

21 January 2018

1 reference

Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial

21 January 2018

1 reference

Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study

21 January 2018

1 reference

Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392).

21 January 2018

1 reference

Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients

21 January 2018

1 reference

A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder

21 January 2018

1 reference

Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

Efficacy of aripiprazole in comorbid addiction in bipolar disorder.

21 January 2018

1 reference

Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder

21 January 2018

1 reference

Safety and tolerability associated with second-generation antipsychotic polytherapy in bipolar disorder: findings from the Systematic Treatment Enhancement Program for Bipolar Disorder

21 January 2018

1 reference

Functional Impairment in Patients with Remitted Bipolar Disorder

21 January 2018

1 reference

Should antipsychotics take pole position in mania treatment?

21 January 2018

1 reference

The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study

21 January 2018

1 reference

12 December 2020

Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group

1 reference

12 December 2020

Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines

1 reference

12 December 2020

Practice guideline for the treatment of patients with bipolar disorder (revision)

1 reference

12 December 2020

Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole.

1 reference

12 December 2020

Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder

1 reference

12 December 2020

Treating bipolar disorder: monotherapy versus combination therapy.

1 reference

12 December 2020

Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol

1 reference

12 December 2020

Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study

1 reference

12 December 2020

A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania

1 reference

12 December 2020

Identifiers

DOI

10.1111/CNS.12017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493634&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493634&resulttype=core&format=json

14 May 2020

23095277

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493634&resulttype=core&format=json